Thompson Davis & Co’s PRA Health Sciences, Inc. PRAH Stock Holding History

Thompson Davis & Co’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$39K	Buy	350 +100	+40%	+$10.4K	0.09%	244
2018 Q2	$23K	Hold	250	–	–	0.05%	297
2018 Q1	$21K	Hold	250	–	–	0.06%	289
2017 Q4	$23K	Hold	250	–	–	0.05%	304
2017 Q3	$19K	Hold	250	–	–	0.03%	501
2017 Q2	$19K	Hold	250	–	–	0.03%	495
2017 Q1	$16K	Hold	250	–	–	0.02%	574
2016 Q4	$14K	Sell	250 -375	-60%	-$20.6K	0.02%	620
2016 Q3	$35K	Buy	625 +500	+400%	+$24.5K	0.06%	308
2016 Q2	$5K	Buy	+125	New	+$5.76K	0.01%	801
2016 Q1	–	Sell	-2,125	Closed	-$96K	–	1201
2015 Q4	$96K	Buy	2,125 +2,000	+1,600%	+$84K	0.14%	165
2015 Q3	$5K	Buy	+125	New	+$5K	0.01%	853
2015 Q1	–	Sell	-125	Closed	-$3K	–	1292
2014 Q4	$3K	Buy	+125	New	+$2.82K	﹤0.01%	1072

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Thompson Davis & Co's PRAH Position: Q3 2018 in Review

Thompson Davis & Co increased its PRA Health Sciences, Inc. (PRAH) stake by 40% in Q3 2018, buying an estimated $10.4K and bringing the position to 350 shares worth $39K. The position accounts for 0.09% of the portfolio, ranked #244.

Thompson Davis & Co first reported a position in PRAH in Q4 2014 and has held it in 13 quarters since. The position peaked at $96K in Q4 2015. 342 funds tracked by Wall St. Rank hold PRAH as of Q3 2018.

Thompson Davis & Co held 350 shares of PRA Health Sciences, Inc. worth $39K as of Q3 2018.
Thompson Davis & Co bought 100 PRA Health Sciences, Inc. shares in Q3 2018, an estimated $10.4K.
PRA Health Sciences, Inc. made up 0.09% of Thompson Davis & Co's portfolio in Q3 2018, its #244 holding.
Thompson Davis & Co first reported a position in PRA Health Sciences, Inc. in Q4 2014 and has held it in 13 quarters since.
Thompson Davis & Co's PRA Health Sciences, Inc. position peaked at $96K in Q4 2015.
342 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.